From today, patients with advanced melanoma will be able to access two publicly funded immunotherapy treatments - Opdivo and Keytruda, including Aucklander Barry Hawes.
Show status: Off air
Recent stories from Checkpoint
Get the RNZ app
for easy access to all your favourite programmes
